Key Points
- Omada President Wei-Li Shao sold 2,829 shares on April 8 at an average price of $12.71 (about $35,957) under a pre-arranged Rule 10b5-1 plan, trimming ownership by 0.85% while still holding 328,850 shares (~$4.18M).
- The stock opened Friday at $11.41 and was down 4.8%; Omada has a market cap of $672.3M, a negative PE of -67.12, and a 52-week range of $10.28 to $28.40 (50-day MA $12.74, 200-day MA $17.04).
- Omada reported quarterly EPS of $0.08 (beating estimates by $0.12) on $75.85M revenue, and analyst coverage remains largely positive with an average target of $22 and an overall rating of "Moderate Buy" despite several recent price-target cuts.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) President Wei-Li Shao sold 2,829 shares of the stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $12.71, for a total value of $35,956.59. Following the completion of the sale, the president directly owned 328,850 shares of the company's stock, valued at approximately $4,179,683.50. This trade represents a 0.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Omada Health Stock Down 4.8%
Shares of Omada Health stock opened at $11.41 on Friday. The company has a market cap of $672.28 million and a PE ratio of -67.12. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $28.40. The business has a 50 day moving average price of $12.74 and a 200-day moving average price of $17.04.
Omada Health (NASDAQ:OMDA - Get Free Report) last issued its quarterly earnings data on Thursday, March 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.12. The company had revenue of $75.85 million during the quarter.
Hedge Funds Weigh In On Omada Health
Several institutional investors and hedge funds have recently bought and sold shares of OMDA. Cigna Investments Inc. New bought a new position in Omada Health during the third quarter valued at $76,161,000. Perceptive Advisors LLC bought a new position in Omada Health during the second quarter valued at $44,402,000. Millennium Management LLC boosted its holdings in shares of Omada Health by 1,195.0% in the fourth quarter. Millennium Management LLC now owns 2,272,168 shares of the company's stock worth $35,855,000 after acquiring an additional 2,096,705 shares during the period. Divisadero Street Capital Management LP bought a new position in shares of Omada Health in the third quarter worth $30,510,000. Finally, Jefferies Financial Group Inc. bought a new position in shares of Omada Health in the fourth quarter worth $16,948,000.
Analyst Ratings Changes
Several analysts have recently commented on OMDA shares. BMO Capital Markets lowered their price objective on Omada Health from $27.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, March 6th. Wall Street Zen raised Omada Health from a "hold" rating to a "buy" rating in a research note on Saturday, March 14th. Canaccord Genuity Group decreased their price target on Omada Health from $28.00 to $22.00 and set a "buy" rating for the company in a research report on Friday, March 6th. JPMorgan Chase & Co. decreased their price target on Omada Health from $32.00 to $26.00 and set an "overweight" rating for the company in a research report on Thursday, March 12th. Finally, The Goldman Sachs Group decreased their price target on Omada Health from $26.00 to $23.00 and set a "buy" rating for the company in a research report on Thursday. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Omada Health currently has an average rating of "Moderate Buy" and an average target price of $22.00.
Check Out Our Latest Report on Omada Health
Omada Health Company Profile
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
